IP Library Assignment 029734/0206
Patent Assignment
Reel/Frame 029734/0206

Assignment of Assignor's Interest

Recorded: 2013-01-31 Pages: 9
Assignor
BIOSANTE PHARMACEUTICALS, INC.
Executed: 2013-01-31
Assignee
ADURO GVAX INC.
626 BANCROFT WAY, #3C, BERKELEY, CALIFORNIA, 94710-2224
Covered Properties (13)
Novel Cancer-Associated Antigens and Methods of Their Identification and Use
Patent: 7,217,421 →
Application: 09/610,891 →
Directly Injectable Formulations Which Provide Enhanced Cryoprotection of Cell Products
Patent: 7,176,022 →
Application: 10/323,664 →
Publication: US 2004/0121300
Novel Cancer-Associated Antigens and Methods of Their Identification and Use
Patent: 7,226,606 →
Application: 11/274,856 →
Publication: US 2006/0078544
Cancer Immunotherapy Compositions and Methods of Use
Patent: 7,919,079 →
Application: 11/729,339 →
Publication: US 2008/0014222
Novel Cancer-Associated Antigens and Methods of Their Identification and Use
Patent: 7,645,587 →
Application: 11/799,584 →
Publication: US 2007/0212739
Methods and Compositions for Identifying a Cellular Immune Response Against Prostate Cancer
Patent: 7,901,902 →
Application: 11/881,808 →
Publication: US 2009/0053750
Methods and Compositions for Identifying Prostate Cancer or a Humoral Immune Response Against Prostate Cancer
Patent: 7,939,271 →
Application: 12/041,369 →
Publication: US 2008/0279831
Methods and Compositions for Treating Prostate Cancer or Inducing a Humoral Immune Response Against Prostate Cancer
Patent: 8,840,881 →
Application: 12/546,399 →
Publication: US 2010/0150946
Methods and Compositions for Identifying Lung Cancer or a Humoral Immune Response Against Lung Cancer
Application: 12/810,002 →
Publication: US 2011/0038801
Pd-1 Antibodies in Combination with a Cytokine-Secreting Cell and Methods of Use Thereof
Patent: 8,287,856 →
Application: 12/839,163 →
Publication: US 2010/0285013
Cancer Immunotherapy Compositions and Methods of Use
Application: 13/026,180 →
Publication: US 2013/0309267
Directly Injectable Formulations Which Provide Enhanced Cryoprotection of Cell Products
Patent: 9,433,204 →
Application: 13/040,685 →
Publication: US 2011/0159585
Pd-1 Antibodies in Combination with a Cytokine-Secreting Cell and Methods of Use Thereof
Patent: 8,580,247 →
Application: 13/619,699 →
Publication: US 2013/0022600
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 15, 2008
From: JOOSS, KARIN; HARDING, THOMAS; NGUYEN, MINH; KOPRIVNIKAR, KATHRYN E.
To: CELL GENESYS, INC.
Reel/Frame 020803/0098 →
Assignment of Assignor's Interest Oct 10, 2008
From: BAE, JOOEUN; JOOSS, KARIN
To: CELL GENESYS, INC.
Reel/Frame 021670/0335 →
Merger Nov 12, 2009
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023509/0320 →
Assignment of Assignor's Interest Nov 18, 2009
From: SIMMONS, ANDREW; JOOSS, KARIN
To: CELL GENESYS, INC.
Reel/Frame 023536/0110 →
Assignment of Assignor's Interest Nov 18, 2009
From: ALLISON, JAMES
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 023536/0067 →
Assignment of Assignor's Interest Nov 23, 2009
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023557/0481 →
Assignment of Assignor's Interest Jan 14, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023783/0589 →
Assignment of Assignor's Interest Feb 2, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023973/0005 →
Assignment of Assignor's Interest Apr 5, 2010
From: JOOSS, KARIN; NGUYEN, MINH; KOPRIVNIKAR, KATHRYN E.; HARDING, THOMAS
To: CELL GENESYS, INC.
Reel/Frame 024188/0141 →
Assignment of Assignor's Interest Nov 1, 2010
From: JOOSS, KARIN; SIMMONS, ANDREW
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 025229/0655 →
Assignment of Assignor's Interest May 8, 2014
From: KORMAN, ALAN J.
To: MEDAREX, INC.
Reel/Frame 032851/0777 →
Merger May 8, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 032851/0890 →
Merger Jun 3, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035778/0484 →
Merger Apr 26, 2017
From: CELL GENESYS, INC
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 042117/0971 →
Nunc Pro Tunc Assignment Apr 26, 2017
From: BIOSANTE PHARMACEUTICALS, INC.
To: ADURO GVAX, INC.
Reel/Frame 042117/0900 →
Confirmatory License Oct 31, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044636/0205 →
Confirmatory License Oct 31, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044327/0491 →
Security Interest Dec 29, 2017
From: ANI PHARMACEUTICALS, INC.
To: CITIZENS BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044504/0575 →
Security Interest Dec 27, 2018
From: ANI PHARMACEUTICALS, INC.
To: CITIZENS BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 047860/0931 →
Assignment of Assignor's Interest Jun 2, 2021
From: ADURO GVAX, INC.
To: HEALTHTREE, INC.
Reel/Frame 056416/0653 →
Assignment of Assignor's Interest Sep 3, 2021
From: CHINOOK THERAPEUTICS, INC.
To: HEALTHTREE, INC.
Reel/Frame 057385/0434 →
Release of Security Interest Nov 24, 2021
From: CITIZENS BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANIP ACQUISITION COMPANY; ANI PHARMACEUTICALS, INC.
Reel/Frame 058207/0891 →
Release of Security Interest Nov 24, 2021
From: CITIZENS BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANI PHARMACEUTICALS, INC.; ANIP ACQUISITION COMPANY
Reel/Frame 058207/0746 →